Ad
related to: dedifferentiated endometrial carcinoma treatment guidelines 1- EC Treatment Options
Learn About An Endometrial Cancer
Treatment Option For Your Patients.
- EC Treatment Information
Read About A Type Of EC Treatment
And View Treatment Information.
- Review A Safety Profile
See The Adverse Reactions Of A
Pivotal Clinical Trial.
- Discover A Trial
To Understand The Efficacy
Of An Endometrial Cancer Treatment.
- Dosing Information
Get The Dosing & Administration
Information For An EC Treatment.
- Access & Support Options
Explore The Options Together
In One Easy-To-Access Location.
- EC Treatment Options
Search results
Results From The WOW.Com Content Network
Serous carcinoma is a Type II endometrial tumor that makes up 5–10% of diagnosed endometrial cancer and is common in postmenopausal women with atrophied endometrium and black women. Serous endometrial carcinoma is aggressive and often invades the myometrium and metastasizes within the peritoneum (seen as omental caking ) or the lymphatic system.
High-grade serous carcinoma (HGSC) is a type of tumour that arises from the serous epithelial layer in the abdominopelvic cavity and is mainly found in the ovary.HGSCs make up the majority of ovarian cancer cases [1] and have the lowest survival rates. [2]
Treatment of uterine cancer may differ depending on the type of cancer and staging of the tumor. [15] In early stages, minimal invasive surgery is preferred. [16] For endometrial cancer, five main types of treatments are used, including surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy
There is an association with endometriosis and concurrent primary endometrial carcinoma (endometrial cancer). On gross pathological examination, the tumor is cystic and may be solid and some arise in cystic endometriosis. In 40% of cases, endometrioid tumors are found bilaterally. [3]
Carcinosarcoma of the uterus. In gross appearance, MMMTs are fleshier than adenocarcinomas, may be bulky and polypoid, and sometimes protrude through the cervical os.On histology, the tumors consist of adenocarcinoma (endometrioid, serous or clear cell) mixed with the malignant mesenchymal elements; alternatively, the tumor may contain two distinct and separate epithelial and mesenchymal ...
Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy , prompted by post-menopausal bleeding .
Dedifferentiation (pronounced dē-ˌdi-fə-ˌren-chē-ˈā-shən) is a transient process by which cells become less specialized and return to an earlier cell state within the same lineage. [1] This suggests an increase in cell potency , meaning that, following dedifferentiation, a cell may possess the ability to re-differentiate into more cell ...
Adenosarcoma (also Müllerian adenosarcoma) is a rare malignant tumor that occurs in women of all age groups, but most commonly post-menopause.Adenosarcoma arises from mesenchymal tissue and has a mixture of the tumoral components of an adenoma, a tumor of epithelial origin, and a sarcoma, a tumor originating from connective tissue.
Ad
related to: dedifferentiated endometrial carcinoma treatment guidelines 1